Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 9/1/00 → 9/1/02 |
A Phase II, Randomized, Double-blind, Active-controlled, Dose-escalation Study to Determine the Maximum Well-tolerated Dose of Ropinirole Controlled-release (CR) in Parkinson's Disease Patients Not Receiving Other Dopaminergic Therapies
- Slevin, John (PI)